What test will I require for age related macular degeneration?
The main test that has now revolutionized how we manage the retinal disease is called optical coherence tomography. Using light we are able to take cross sections of the retina which allows us to see the retinal layers in unprecedented detail. That allows us to see fluid far more sensitively than we can with clinical examination and its earlier stages. It facilitates our abilities to make diagnoses. It also facilitates our ability to determine how you’re responding to the novel treatments that we are using – including injections into the eye.
By using optical coherence tomography we can also determine how many injections you require, how frequently they are required. The other investigation that is often undertaken is fundus fluorescein angiography. That’s where an injection of a fluorescent dye is given in the back of the hand, which then circulates around the body till it gets to the back of the eye into the blood vessels in the retina and allows us to visualise the blood supply in the retina, to see if there is any leakage of the dye out of the blood vessels in the retina. Then again it allows us to direct our treatment to the areas of leakage if necessary.
More about Michel Michaelides
Professor Michel Michaelides is a Professor of Ophthalmology at Clinica London. His special expertise is in Retinal Diseases, including Inherited Retinal Diseases, Age Related Macular Degeneration, Diabetic Retinopathy and Maculopathy, and Retinal Vein Occlusions.
He has over 16 years experience in treating people with eye problems just like you, and has published extensively in scientific journals about diabetic eye disease, age-related macular degeneration and inherited eye disease, and also lead multiple clinical trials investigating novel therapies. At Clinica London, he is responsible for Retinal Diseases both in adults and children.